GC Cell announced on the 31st that its HER2-targeted allogeneic CAR-NK cell therapy, 'AB-201 (GCC2003),' has received simultaneous approvals for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback